Gujarat Kidney And Super Speciality (NSE:GKSL) Marketable Securities: ₹462.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GKSL Gujarat Kidney And Super Speciality Ltd NSE:GKSL
18 GF Score
Price ₹130.55
! 3 Warning Signs
View Full Analysis

What is Gujarat Kidney And Super Speciality Marketable Securities?

Gujarat Kidney And Super Speciality NSE:GKSL +0.33% 18 Marketable Securities is ₹462.1 Mil as of Mar. 2026. GuruFocus rates NSE:GKSL with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Gujarat Kidney And Super Speciality's Marketable Securities for the quarter that ended in Mar. 2026 was ₹462.1 Mil.

Gujarat Kidney And Super Speciality's annual Marketable Securities declined from Mar. 2024 (₹5.4 Mil) to Mar. 2025 (₹4.7 Mil) but then increased from Mar. 2025 (₹4.7 Mil) to Mar. 2026 (₹462.1 Mil).

Gujarat Kidney And Super Speciality  (NSE:GKSL) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Gujarat Kidney And Super Speciality Marketable Securities Related Terms

Gujarat Kidney And Super Speciality Marketable Securities Historical Data

* Premium members only.

The historical data trend for Gujarat Kidney And Super Speciality's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality Marketable Securities Chart

Gujarat Kidney And Super Speciality Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Marketable Securities
2.75 5.40 4.73 462.10

Gujarat Kidney And Super Speciality Quarterly Data
Mar23 Mar24 Dec24 Mar25 Jun25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial 0.00 4.73 5.78 0.00 462.10
NSE:GKSL
18GF Score
Gujarat Kidney And Super Speciality Ltd NSE:GKSL
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gujarat Kidney And Super Speciality Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹462.1 Mil mean?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a Marketable Securities of ₹462.1 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Gujarat Kidney And Super Speciality and its competitors.
Is Gujarat Kidney And Super Speciality's Marketable Securities too high?
Gujarat Kidney And Super Speciality's current Marketable Securities is ₹462.1 Mil. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's Marketable Securities compare to HCA and THC?
Gujarat Kidney And Super Speciality's Marketable Securities of ₹462.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Gujarat Kidney And Super Speciality and its competitors. Gujarat Kidney And Super Speciality's current Marketable Securities is ₹462.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current Marketable Securities of ₹462.1 Mil. The current Marketable Securities is ₹462.1 Mil. Gujarat Kidney And Super Speciality's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current Marketable Securities is ₹462.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gujarat Kidney And Super Speciality Business Description

Other Exchanges 544666:India
Address Jetalpur Road, Gokak Mill Compound, Plot No. 1, City Sarve No. 1537/A, Jetalpur Bridge, Anand Nagar, Haripura, Alkapuri, Vadodara, GJ, IND, 390 020
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
18GF Score

Get the complete analysis for NSE:GKSL

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹130.55
Price